+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Immunometabolic Diseases and Clinical Research · Registering as Listener

ICIDCR
📅 30 Sep – 1 Oct 2026 📍 Jeddah, Saudi Arabia 👥 Standard / Physical Participation
Listener Registration From
$205
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit
Standard Registration Closed — You may continue with Virtual Registration to join the conference remotely.

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Immunometabolic Diseases and Clinical Research
ModeVirtual
ParticipationListener
Registration fee$145.00
Bank charges (5.8%)$8.41
Total payable $153.41

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 2 SDG 3 SDG 4 SDG 9

This session will explore the intricate metabolic pathways that govern immune cell function and differentiation. Understanding these mechanisms is crucial for developing targeted therapies for immunometabolic diseases.

This track focuses on bridging basic research and clinical applications in immunometabolism. Presentations will highlight innovative strategies to translate findings into effective treatments for metabolic disorders.

This session will examine the interplay between inflammation and metabolic dysregulation in various diseases. Discussions will center on how immune responses contribute to the pathogenesis of metabolic disorders.

This track will address the role of clinical immunology in understanding and managing metabolic health. Participants will share insights on immune profiling and its implications for metabolic disease outcomes.

This session will review the latest advancements in immunometabolic therapies and their clinical applications. Experts will discuss novel therapeutic strategies aimed at modulating immune responses to improve metabolic health.

This track will delve into the regulatory mechanisms of the immune system in the context of metabolic disorders. Presentations will highlight how immune regulation can influence disease progression and treatment.

This session will focus on the identification and validation of biomarkers relevant to immunometabolic diseases. Researchers will present findings that could enhance diagnostic and therapeutic approaches.

This track will explore the interactions between diet, gut microbiota, and immune metabolism. Discussions will emphasize how these factors contribute to the development and management of metabolic diseases.

This session will investigate how cellular metabolism influences immune function and responses. Insights into metabolic reprogramming of immune cells will be discussed in relation to disease mechanisms.

This track will showcase novel experimental models used to study immunometabolic diseases. Presenters will discuss the advantages and limitations of these models in advancing our understanding of disease mechanisms.

This session will provide a platform for discussing the global burden of immunometabolic diseases and the disparities in clinical research. Participants will share insights on collaborative efforts to address these challenges.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED